Langerhans cell histiocytosis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Langerhans cell histiocytosis}} | {{Langerhans cell histiocytosis}} | ||
{{CMG}} {{AE}} {{HL}} | |||
==Overview== | |||
==Screening== | |||
==References== | ==References== | ||
| Line 10: | Line 11: | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 13:17, 4 February 2016
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis screening On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis screening |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]